Last reviewed · How we verify

NCT03902925

Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia

Completed Phase 1, PHASE2 Last updated 4 November 2019
What this trial tests

Phase 1, PHASE2 trial testing Topical lidocaine 2% jelly plus sub-tenon ropivacaine 10% injection in Retinal Disease in 56 participants. Completed in 31 October 2019.

Timeline
1 January 2019
Primary endpoint
31 August 2019
31 October 2019

Quick facts

Lead sponsorUniversity of Sao Paulo
PhasePhase 1, PHASE2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment56
Start date1 January 2019
Primary completion31 August 2019
Estimated completion31 October 2019
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

18 and older, any sex, with Retinal Disease or Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vitreoretinal surgery has evolved to less invasive procedures, and it is used to treat a wide range of diseases. So anesthesia for vitreoretinal procedures has evolved, promoting adequate analgesia while reducing risks to the patient. In the present study two types of procedures for anesthesia during vitreoretinal surgery are evaluated regarding the pain referred by the patient during the whole procedure: peribulbar anesthesia versus sub-tenon injection plus topical jelly anesthesia. Through the comparative analysis of the pain scale of the two groups it is expected that the two modalities present the same anesthetic efficacy, showing that the methods used may be equivalent.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pain during pars plana vitrectomy following sub-Tenon versus peribulbar anesthesia: A randomized trial.
    Ribeiro JAS, Ribeiro DS, Scott IU, Abrão J, et al · · 2020 · cited 11× · PMID 32760093 · DOI 10.1371/journal.pone.0236624

Verify or expand the search:

Other recruiting trials for Retinal Disease

Currently open trials in the same condition.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902925.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing